| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.21 | 0.2 |